Skip to main navigation Skip to search Skip to main content

Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity...

Project: Research

Project Details

StatusFinished
Effective start/end date11/10/0905/31/17

Funding

  • Novartis Pharmaceuticals Corporation: $56,869.41